Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

  1. Ortega, V.
  2. Antón, A.
  3. Garau, I.
  4. Afonso, N.
  5. Calvo, L.
  6. Fernández, Y.
  7. Martínez-García, M.
  8. Blanco, E.
  9. Zamora, P.
  10. García, M.
  11. Illarramendi, J.J.
  12. Rodríguez Sánchez, C.A.
  13. Sampayo, M.
  14. Aguirre, E.
  15. Pérez-García, J.M.
  16. Cortés, J.
  17. Llombart-Cussac, A.
Revue:
Clinical Breast Cancer

ISSN: 1938-0666 1526-8209

Année de publication: 2019

Volumen: 19

Número: 2

Pages: 105-112

Type: Article

DOI: 10.1016/J.CLBC.2018.12.012 GOOGLE SCHOLAR

Objectifs de Développement Durable